Skip to main content

and
  1. Article

    Ibrutinib in combination with rituximab is highly effective in treatment of chronic lymphocytic leukemia patients with steroid refractory and relapsed autoimmune cytopenias

    Autoimmune hemolytic anemia (AIHA) and pure red cell aplasia (PRCA) are common complications of CLL. The optimal treatment of steroid refractory AIHA/PRCA is not well established. We conducted a multicenter st...

    Eugene Nikitin, Maria Kislova, Dmitry Morozov, Vera Belyakova, Anna Suvorova in Leukemia (2023)